A Longitudinal Observational Study of Patients Undergoing Therapy for IMISC

Description

TARGET-DERM is a longitudinal, observational study of adult and pediatric patients being managed for Atopic Dermatitis and other Immune-Mediated Inflammatory Skin Conditions (IMISC) in usual clinical practice. TARGET-DERM will create a research registry of patients with IMISC within academic and community real-world practices in order to assess the safety and effectiveness of current and future therapies.

Conditions

Atopic Dermatitis, Alopecia Areata, Hidradenitis Suppurativa, Vitiligo, Psoriasis, Chronic Spontaneous Urticaria

Talk to us

Study Overview

On this page

Study Details

Study overview

TARGET-DERM is a longitudinal, observational study of adult and pediatric patients being managed for Atopic Dermatitis and other Immune-Mediated Inflammatory Skin Conditions (IMISC) in usual clinical practice. TARGET-DERM will create a research registry of patients with IMISC within academic and community real-world practices in order to assess the safety and effectiveness of current and future therapies.

A Longitudinal Observational Study of Patients Undergoing Therapy for Immune-Mediated Inflammatory Skin Conditions

A Longitudinal Observational Study of Patients Undergoing Therapy for IMISC

Condition
Atopic Dermatitis
Intervention / Treatment

-

Contacts and Locations

Scottsdale

Clear Dermatology & Aesthetics Center/Investigative MD, Scottsdale, Arizona, United States, 85255

Fort Smith

Johnson Dermatology, Fort Smith, Arkansas, United States, 72916

Little Rock

University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States, 72205

Little Rock

Arkansas Dermatology, Little Rock, Arkansas, United States, 72223

Fountain Valley

First OC Dermatology, Fountain Valley, California, United States, 92708

Fremont

Center for Dermatology Cosmetic and Laser Surgery, Fremont, California, United States, 94538

Irvine

University of California, Irvine, California, United States, 92697

San Diego

University of California - San Diego/Rady Children's Hospital, San Diego, California, United States, 92123

Washington

George Washington University, Washington, District of Columbia, United States, 20037

Hollywood

Feinstein Dermatology and Cosmetic Surgery, Hollywood, Florida, United States, 33021

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * 1. Adults and children (all ages) with Atopic Dermatitis or other Immune-mediated Inflammatory Skin Conditions been prescribed any dermatologic treatment.
  • * 2. Participant has plans for future visits at the site for continued management of IMISC.
  • * 1. Inability to provide written informed consent/assent.
  • * 2. Subjects participating in any interventional study or trial for IMISC treatment trial at the time of enrollment. Patients may be enrolled in TARGET-DERM once participation in the trial is complete. Note: Participants may be enrolled in other registries or studies where IMISC treatment outcomes are observed and/or reported (such as center-based registries).

Ages Eligible for Study

to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Target PharmaSolutions, Inc.,

Laura Dalfonso, STUDY_DIRECTOR, Target RWE

Study Record Dates

2050-12